GenomeKey
Founded 2019 · $11.7M raised
- Founded
- 2019
- Business Model
- B2B
- Website
- genomekey.com
- Total Funding
- $11.7M
- Last Round
- $11.4M GrantApr 2021
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
UK biotechnology company using AI machine learning to build an in vitro diagnostic device that identifies bacterial species and antibiotic resistance directly from patient blood.
Summary
GenomeKey is an Artificial Intelligence company, founded in 2019. It has raised $11.7M in total across 2 rounds, most recently a $11.4M Grant round in Apr 2021. Investors include CARB-X and Bristol Private Equity Club.
Funding History
Apr 2021
Sign up to see all 2 events
Funding: Angel through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/genomekey"><img src="https://indexed.vc/api/badge/company/genomekey" alt="GenomeKey on Indexed.vc" width="260" height="76" /></a>